Anoek L I van Leeuwen1,2, Nicole A M Dekker1,2, Elise P Jansma3,4, Christa Boer1, Charissa E van den Brom1,2. 1. Department of Anesthesiology, Experimental Laboratory for VItal Signs, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands. 2. Department of Physiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands. 3. Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit, Amsterdam Public Health research institute, Amsterdam, The Netherlands. 4. Medical Library, Vrije Universiteit, Amsterdam, The Netherlands.
Abstract
OBJECTIVE: Microcirculatory perfusion disturbances following hemorrhagic shock and fluid resuscitation contribute to multiple organ dysfunction and mortality. Standard fluid resuscitation is insufficient to restore microcirculatory perfusion; however, additional therapies are lacking. We conducted a systematic search to provide an overview of potential non-fluid-based therapeutic interventions to restore microcirculatory perfusion following hemorrhagic shock. METHODS: A structured search of PubMed, EMBASE, and Cochrane Library was performed in March 2020. Animal studies needed to report at least one parameter of microcirculatory flow (perfusion, red blood cell velocity, functional capillary density). RESULTS: The search identified 1269 records of which 48 fulfilled all eligibility criteria. In total, 62 drugs were tested of which 29 were able to restore microcirculatory perfusion. Particularly, complement inhibitors (75% of drugs tested successfully restored blood flow), endothelial barrier modulators (100% successful), antioxidants (66% successful), drugs targeting cell metabolism (83% successful), and sex hormones (75% successful) restored microcirculatory perfusion. Other drugs consisted of attenuation of inflammation (100% not successful), vasoactive agents (68% not successful), and steroid hormones (75% not successful). CONCLUSION: Improving mitochondrial function, inhibition of complement inhibition, and reducing microvascular leakage via restoration of endothelial barrier function seem beneficial to restore microcirculatory perfusion following hemorrhagic shock and fluid resuscitation.
OBJECTIVE: Microcirculatory perfusion disturbances following hemorrhagic shock and fluid resuscitation contribute to multiple organ dysfunction and mortality. Standard fluid resuscitation is insufficient to restore microcirculatory perfusion; however, additional therapies are lacking. We conducted a systematic search to provide an overview of potential non-fluid-based therapeutic interventions to restore microcirculatory perfusion following hemorrhagic shock. METHODS: A structured search of PubMed, EMBASE, and Cochrane Library was performed in March 2020. Animal studies needed to report at least one parameter of microcirculatory flow (perfusion, red blood cell velocity, functional capillary density). RESULTS: The search identified 1269 records of which 48 fulfilled all eligibility criteria. In total, 62 drugs were tested of which 29 were able to restore microcirculatory perfusion. Particularly, complement inhibitors (75% of drugs tested successfully restored blood flow), endothelial barrier modulators (100% successful), antioxidants (66% successful), drugs targeting cell metabolism (83% successful), and sex hormones (75% successful) restored microcirculatory perfusion. Other drugs consisted of attenuation of inflammation (100% not successful), vasoactive agents (68% not successful), and steroid hormones (75% not successful). CONCLUSION: Improving mitochondrial function, inhibition of complement inhibition, and reducing microvascular leakage via restoration of endothelial barrier function seem beneficial to restore microcirculatory perfusion following hemorrhagic shock and fluid resuscitation.
Authors: Michael T Ganter; Mitchell J Cohen; Karim Brohi; Brian B Chesebro; Kristan L Staudenmayer; Pamela Rahn; Sarah C Christiaans; Natasha D Bir; Jean-François Pittet Journal: Ann Surg Date: 2008-02 Impact factor: 12.969
Authors: David N Naumann; Jon Hazeldine; Mark J Midwinter; Sam D Hutchings; Paul Harrison Journal: J Trauma Acute Care Surg Date: 2018-01 Impact factor: 3.313
Authors: M Pape; G F Giannakópoulos; W P Zuidema; E S M de Lange-Klerk; E J Toor; M J R Edwards; M H J Verhofstad; T N Tromp; E M M van Lieshout; F W Bloemers; L M G Geeraedts Journal: Scand J Trauma Resusc Emerg Med Date: 2019-02-13 Impact factor: 2.953
Authors: Anoek L I van Leeuwen; Nicole A M Dekker; Elise P Jansma; Christa Boer; Charissa E van den Brom Journal: Microcirculation Date: 2020-08-20 Impact factor: 2.628